Omicron is a heavily mutated variant of SARS-CoV-2 first reported to the World Health Organization by the Network for Genomics Surveillance in South Africa on 24 November 2021. It was first detected i
Comparison of mutation prevalence for ORF1a, ORF1b, and S genes of Omicron lineages that are designated Variants of Concern. Characteristic mutations for a lineage are defined as nonsynonymous substitutions or deletions that occur in > 75% of sequences within that lineage.
False-color transmission electron micrograph of an Omicron variant coronavirus, shown in pink, replicating within the cytoplasm of an infected Vero cell
Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also dev
Stanley Erck (right) and Gregory Glenn (left) at the biotech labs in Gaithersburg during the visit of the Governor of Maryland in September 2020
Novavax research and development laboratories in Gaithersburg
Governor Larry Hogan at Novavax's future Vaccines Innovation Campus and global headquarters in Maryland